Neovacs SA Financial Results for 2012
3/29/2013 9:33:02 AM
More...
|
Neovacs SA Release: Publication in the Journal Arthritis & Rheumatism of an Article on Active Immunization With Ifn?-Kinoid in Lupus
2/7/2013 12:48:51 PM
More...
|
Neovacs SA: Final Results of the Phase II Study in Crohn's
11/20/2012 12:19:36 PM
More...
|
Interim Results from Neovacs SA' Phase II Clinical Trial in Crohn's Disease
6/5/2012 11:30:27 AM
More...
|
Neovacs SA Major Milestone Achieved: The Phase IIa Clinical Trial in Rheumatoid Arthritis Meets Its Endpoint
1/5/2012 9:23:22 AM
More...
|
Neovacs SA Announces the Completion of Patient Recruitment in Its International Phase II Clinical Trial of TNF-Kinoid in Crohn's Disease
12/15/2011 10:20:17 AM
More...
|
Neovacs SA Announces Positive Phase 2a Trial Results for TNF Kinoid in Rheumatoid Arthritis Patients
10/26/2011 1:01:38 PM
More...
|
Neovacs SA Phase I/II Results in Lupus Patients Selected for an Oral Presentation at the ACR/ARHP Annual Scientific Meeting, November 8th, 2011 in Chicago
8/25/2011 12:13:14 PM
More...
|
Neovacs SA: New Promising Data in the Phase I/II Clinical Trial in Lupus Patients: Data from the Last Cohort of Patients (240 Mcg) Confirm the Safety, Immunogenicity and Pharmacodynamic of IFN-K
7/26/2011 2:23:17 PM
More...
|
Neovacs SA Receives a Payment of €1,448 Million from OSEO Following Achievement of the Second Key Milestone in the Tracker Project with TNF-Kinoid in Rheumatoid Arthritis
6/9/2011 12:52:55 PM
More...
|
|